1.34
Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo! Finance Canada
Published on: 2025-11-04 05:50:05 - newser.com
Regression analysis insights on Ovid Therapeutics Inc. performanceWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Ovid Therapeutics Inc.CEO Change & AI Driven Price Predictions - newser.com
Visual analytics tools that track Ovid Therapeutics Inc. performance2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - newser.com
Visual trend scoring systems applied to Ovid Therapeutics Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
How Ovid Therapeutics Inc. (1OT) stock correlates with oil marketsJuly 2025 Intraday Action & AI Driven Stock Movement Reports - newser.com
Using flow based indicators on Ovid Therapeutics Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com
What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
What analysts say about Ovid Therapeutics Inc 1OT stockSector Leadership Analysis & Low Risk Capital Appreciation - earlytimes.in
Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat
Ovid Therapeutics Raises $175 Million Through PIPE Financing - Finimize
Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq
Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br
OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):